Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
1999
HIV Coreceptors and Chemokines as Therapeutic Targets Against HIV/AIDS
Clinical Pharmacokinetics of Antiretroviral Drugs
Antiretroviral Therapy in Patients with Suboptimal Virologic Suppression
HIV-1 Long-Term non-progression: More Open Questions than Answers
HIV Escape at Late Stage may be Due to the Lack of V3 Loop Carbohydrates
Analysis of HIV-1 Reverse Transcriptase Activity in Plasma: A New Tool for the Detection of Viral Variants, Virus Load Measurement, and Phenotypic Drug Resistance Testing
Hepatitis B is More Severe in HIV Infection
Did HIV Originate as a Result of Oral Poliovaccine Administration in Africa During the late 50s?
Prediction, Prevention and Treatment of Cytomegalovirus Disease In Persons with AIDS
Discontinuation of Prophylaxis Against Opportunistic Infections in HIV-Infected Persons Receiving Potent Combination Antiretroviral Therapy